Articles tagged with "upadacitinib"

Janus kinase 1 protein.

Researchers Give Update on Janus Kinase (JAK) Inhibitors

May 15, 2020 • By Kimberly Retzlaff

FDA Update: New Drug Approvals, New & Expanded Indications, & More

March 12, 2020 • By Susan Bernstein

Canada & E.U. Approve Upadacitinib for RA

January 28, 2020 • By Michele B. Kaufman, PharmD, BCGP

Rituximab-abbs Available in the U.S.; Plus Upadacitinib in Phase 3 Trials for PsA

November 25, 2019 • By Michele B. Kaufman, PharmD, BCGP

New Options for Treatment-Resistant RA

October 14, 2019 • By Carina Stanton

FDA Approves Upadacitinib for RA

September 2, 2019 • By Michele B. Kaufman, PharmD, BCGP

FDA Approves AbbVie’s New Rheumatoid Arthritis Drug

August 19, 2019 • By Reuters Staff

Upadacitinib + Methotrexate & Other csDMARDs in RA Patients

July 12, 2019 • By Michele B. Kaufman, PharmD, BCGP

Upadacitinib at the FDA

February 28, 2019 • By Michele B. Kaufman, PharmD, BCGP

Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector

December 10, 2018 • By Michele B. Kaufman, PharmD, BCGP